Dermatological Oncology

It is estimated that 1 in 52 men and 1 in 77 women in the US will be diagnosed with melanoma in their lifetime. Despite the fact that melanoma is one of the most rapidly increasing forms of human cancer, new treatments have been slow in developing and the mortality rate continues to rise. We now know that there are several well-defined risk factors for this form of cancer. Our report contains quantitative and qualitative analytical content, covering the present and future of the global cancer drugs market. Although our report is market-centered, we include medical and technical information. We include analyses of under-met market needs from the present looking forward.

GMR Data forecast that Avastin will reach its financial peak by 2018 before losing its patent exclusivity in 2019. The drug is also set to benefit from a potential combination therapy, with EGFL7, for the treatment of colorectal and lung cancer, similar to that of Herceptin and Perjeta.

  • Advances in Treatment Methods
  • Advances in Diagnostic Procedures
  • Advances in Skin Cancer Research
  • Melanoma
  • Actinic keratosis

Related Conference of Dermatological Oncology

December 09-10, 2019

Asian Aesthetic and Dermatology congress

Bangkok, Thailand
December 09-10, 2019

International Conference on Cosmetology & Beauty Expo

Bangkok, Thailand
January 20-21, 2020

2nd International Dermatologists Annual Meeting

Hong Kong
February 20-21, 2020

Asia-Pacific Dermatology & Cosmetology Conference

Kuala Lumpur, Malaysia
March 05-06, 2020 |

20th European Dermatology Congress

Prague, Czech Republic
Mar 23-24, 2020

21st World Dermatology Congress

Tokyo , Japan
March 25-26, 2020

2nd Global Summit on Skincare and Plastic Aesthetic


Madrid | Spain
March 26-27, 2020

22nd World Dermatology and Aesthetic Congress

Abu Dhabi, UAE
April 27-28, 2020

25th International Conference on Dermatology & Skin Care

Amsterdam, Netherlands
May 24-25, 2021

2nd23rd World Dermatology and Aesthetic Congress

Istanbul, Turkey

Dermatological Oncology Conference Speakers